Editors:
- Highlights the most recent advancements reported in the literature on technologies
- Provides a comprehensive discussion of new technologies developed and recently over 40% updated new content
- Essential read for scientists and researchers in pharmaceutical, chemical, and agricultural industries
Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 50)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (14 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
Division of Pharmaceutics, The University of Texas at Austin, Austin, USA
Robert O. Williams III
-
Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, USA
Daniel A. Davis Jr.
-
DisperSol Technologies, LLC, Georgetown, USA
Dave A. Miller
About the editors
Daniel Alan Davis, Jr., Ph.D., Pharm.D.
Daniel Davis received his BS in Chemistry from the University of Texas at Austin in 2015 and PharmD from the University of Texas at Austin College of Pharmacy (UTCOP) in 2019, where he graduated with research honors and academic honors. His research contributions resulted in him receiving the prestigious College of Pharmacy’s Outstanding Research Award. Daniel completed his Ph.D. in 2021 as part of the PharmD/PhD Honor’s program in the Division of Molecular Pharmaceutics and Drug Delivery, and currently works as an associate principal scientist at DisperSol Technologies, LLC. Daniel has Authored six peer-reviewed publications, co-authored three peer-reviewedpublications and eight published abstracts at international pharmaceutical conferences in the area of drug solubilization and amorphous solid dispersions, and he is an inventor on eight patents and patent applications. His research is focused on increasing the solubility of poorly water soluble drugs, specifically focused on innovation formulation designs for increased solubility. Much of this work uses KinetiSol processing, hot melt extrusion and selective laser sintering three-dimensional printing. Daniel received the B. Berard Matthews Endowed Scholarship, the Van Smith Endowed Presidential Scholarship, and the Undergraduate Research Fellowship from the University of Texas at Austin based on his research. Daniel serves as the social media editor for AAPS PharmSciTech and a peer reviewer for the International Journal of Pharmaceutics.
Dave A. Miller, Ph.D. is the Chief Scientific Officer at DisperSol Technologies. Prior to his current position, Dr. Miller servedas Vice President of Research and Development at DisperSol Technologies for ten years. Before joining DisperSol, he was a Senior Principal Scientist at Hoffmann-La Roche. Dr. Miller specializes in formulation and processing technologies for improving oral bioavailability of insoluble small molecules. He has applied his expertise toward advancing numerous drug candidates through all stages of development from early discovery to line extension. Dr. Miller was an original inventor of the pharmaceutical applications of the KinetiSol technology and continues to be a primary innovative driver for application and expansion of the platform. He has published 45 research articles in peer-reviewed journals and authored 8 book chapters, and is co-editor of the First, Second, and Third Editions of the textbook, Formulating Poorly Water-Soluble Drugs. He is a co-inventor on numerous granted and pending patents world-wide. Dr. Miller holds a B.S. in Chemical Engineering and a Ph.D. in Pharmaceuticsfrom the University of Texas at Austin.
Bibliographic Information
Book Title: Formulating Poorly Water Soluble Drugs
Editors: Robert O. Williams III, Daniel A. Davis Jr., Dave A. Miller
Series Title: AAPS Advances in the Pharmaceutical Sciences Series
DOI: https://doi.org/10.1007/978-3-030-88719-3
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: American Association of Pharmaceutical Scientists 2022
Hardcover ISBN: 978-3-030-88718-6Published: 20 May 2022
Softcover ISBN: 978-3-030-88721-6Published: 20 May 2023
eBook ISBN: 978-3-030-88719-3Published: 19 May 2022
Series ISSN: 2210-7371
Series E-ISSN: 2210-738X
Edition Number: 3
Number of Pages: XII, 693
Number of Illustrations: 142 b/w illustrations, 138 illustrations in colour
Topics: Pharmaceutical Sciences/Technology, Pharmacology/Toxicology, Medical Biochemistry